Status:
RECRUITING
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
Lead Sponsor:
Outliers, Inc.
Collaborating Sponsors:
Citruslabs
Conditions:
ADHD
Sleep Disturbance
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects ...
Eligibility Criteria
Inclusion Criteria:
- Aged 18-55 years
- Currently prescribed stimulant medication for ADHD
- Experiencing: sleep difficulty, irritability, anxiety, brain fog
- Stable medication dose ≥3 months
- Healthy with no uncontrolled chronic conditions
- Stable on supplements ≥3 months if applicable
- US resident
- Willing to maintain current habits
Exclusion Criteria:
- Chronic conditions (e.g. cancer, mental illness)
- Use of psychiatric medications besides stimulants
- Pregnancy, breastfeeding, thyroid, liver, kidney conditions
- Recent smokers or heavy alcohol use
- Night shift workers
- Participation in other clinical trials
- Allergies to product ingredients
Key Trial Info
Start Date :
August 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07380412
Start Date
August 12 2025
End Date
March 1 2026
Last Update
February 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Las Vegas, Nevada, United States, 89118